Get started
Author

Paul J. Shin

Observed names: P. Shin, Paul Shin
ORCID: 0000-0001-8301-1079
Observed ORCID: 0000-0001-8301-1079
OpenAlex ID: A5049539733
Genetic Determinants of Outcome in Intrahepatic Cholangiocarcinoma
2021 · Thomas Boerner, Esther Drill, et al. · Hepatology · 174
PDF
Intrahepatic Cholangiocarcinoma with Lymph Node Metastasis: Treatment-Related Outcomes and the Role of Tumor Genomics in Patient Selection
2021 · Joshua S. Jolissaint, Kevin C. Soares, et al. · Clinical Cancer Research · 54
Accuracy of curability expectations in patients with gastrointestinal cancers
2022 · Rajiv Agarwal, Paul Shin, et al. · Cancer Medicine · 10
PDF
SMA-like syndrome with variant mesenteric venous anatomy
2017 · James Shin, Paul J. Shin, et al. · Clinical Imaging · 9
Surgical Margin of Resected Colorectal Liver Metastases
2023 · Sarah M. McIntyre, Kevin C. Soares, et al. · Annals of Surgery · 7
Metastatic Melanoma Outcomes and the Evolving Role of Surgery in the Immunotherapy Era
2025 · Hilary R. Keller, Douglas A. Hanes, et al. · JAMA Surgery · 5
Clinical Utility and Prognostic Implications of Circulating Cell-Free DNA in Biliary Tract Cancer
2025 · Darren Cowzer, Madison Darmofal, et al. · JCO Precision Oncology · 4
Minimally invasive approaches to hepatic arterial infusion pump placement in metastatic colorectal cancer
2020 · Paul J. Shin, T. Peter Kingham · Laparoscopic Surgery · 3
Male or female sex stratified by age does not impact survival in patients with metastatic melanoma receiving immunotherapy
2025 · Hilary R. Keller, Douglas A. Hanes, et al. · The American Journal of Surgery · 1
Importance of Surgical Margins in Patients with Early-Stage Merkel Cell Carcinoma
2025 · Arthur W. Cowman, Kristel Lourdault, et al. · Dermatology and Therapy · 1
Impact of non-metropolitan residence on survival for gastric neuroendocrine tumors
2025 · Hilary R. Keller, Douglas A. Hanes, et al. · The American Journal of Surgery
317P Targeted next generation sequencing (NGS) of cell free (cf) DNA in biliary tract cancer (BTC)
2024 · D. Cowzer, K. Seier, et al. · Annals of Oncology
PDF
Supplementary Data from Intrahepatic Cholangiocarcinoma with Lymph Node Metastasis: Treatment-Related Outcomes and the Role of Tumor Genomics in Patient Selection
2023 · Joshua S. Jolissaint, Kevin C. Soares, et al.
Supplementary Data from Intrahepatic Cholangiocarcinoma with Lymph Node Metastasis: Treatment-Related Outcomes and the Role of Tumor Genomics in Patient Selection
2023 · Joshua S. Jolissaint, Kevin C. Soares, et al.
Figure S4 from Intrahepatic Cholangiocarcinoma with Lymph Node Metastasis: Treatment-Related Outcomes and the Role of Tumor Genomics in Patient Selection
2023 · Joshua S. Jolissaint, Kevin C. Soares, et al.
Figure S4 from Intrahepatic Cholangiocarcinoma with Lymph Node Metastasis: Treatment-Related Outcomes and the Role of Tumor Genomics in Patient Selection
2023 · Joshua S. Jolissaint, Kevin C. Soares, et al.
Figure S1 from Intrahepatic Cholangiocarcinoma with Lymph Node Metastasis: Treatment-Related Outcomes and the Role of Tumor Genomics in Patient Selection
2023 · Joshua S. Jolissaint, Kevin C. Soares, et al.
Figure S2 from Intrahepatic Cholangiocarcinoma with Lymph Node Metastasis: Treatment-Related Outcomes and the Role of Tumor Genomics in Patient Selection
2023 · Joshua S. Jolissaint, Kevin C. Soares, et al.
Figure S3 from Intrahepatic Cholangiocarcinoma with Lymph Node Metastasis: Treatment-Related Outcomes and the Role of Tumor Genomics in Patient Selection
2023 · Joshua S. Jolissaint, Kevin C. Soares, et al.
Data from Intrahepatic Cholangiocarcinoma with Lymph Node Metastasis: Treatment-Related Outcomes and the Role of Tumor Genomics in Patient Selection
2023 · Joshua S. Jolissaint, Kevin C. Soares, et al.
Data from Intrahepatic Cholangiocarcinoma with Lymph Node Metastasis: Treatment-Related Outcomes and the Role of Tumor Genomics in Patient Selection
2023 · Joshua S. Jolissaint, Kevin C. Soares, et al.
Figure S3 from Intrahepatic Cholangiocarcinoma with Lymph Node Metastasis: Treatment-Related Outcomes and the Role of Tumor Genomics in Patient Selection
2023 · Joshua S. Jolissaint, Kevin C. Soares, et al.
Figure S1 from Intrahepatic Cholangiocarcinoma with Lymph Node Metastasis: Treatment-Related Outcomes and the Role of Tumor Genomics in Patient Selection
2023 · Joshua S. Jolissaint, Kevin C. Soares, et al.
Figure S2 from Intrahepatic Cholangiocarcinoma with Lymph Node Metastasis: Treatment-Related Outcomes and the Role of Tumor Genomics in Patient Selection
2023 · Joshua S. Jolissaint, Kevin C. Soares, et al.
Genetic heterogeneity of intrahepatic cholangiocarcinoma: Implications for outcome.
2023 · Yi Song, Thomas Boerner, et al. · Journal of Clinical Oncology
PDF
Works count: 28
Citation count: 268
H-index: 5
I10-index: 3
Year
Topic
Type